✦ LIBER ✦

100 Peginterferon alfa-2A (40KD) with or without ribavirin in the treatment of recurrent hepatitis C after liver transplantation: Preliminary report of a randomized study

✍ Scribed by A. Petrolati; R. Lionetti; F. Donato; M. Merli; P. Burra; P. Angeli; M. Strazzabosco; G. Tisone; M. Angelico

Book ID: 117372930
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 64 KB
Volume: 40
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(04)90100-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of recurrent hepatitis C after

Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination

✍ Jérôme Dumortier; Jean-Yves Scoazec; Philippe Chevallier; Olivier Boillot 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 225 KB

A randomized study on Peg-interferon alf

A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C

✍ Mario Angelico; Alessandra Petrolati; Raffaella Lionetti; Ilaria Lenci; Patrizia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 158 KB

775 Treatment of recurrent hepatitis C a

775 Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2B and ribavirin combination

✍ Jerome Dumortier; Jean-Yves Scoazec; Philippe Chevallier; Olivier Boillot 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection

✍ Peter Ferenci; Elisabeth Formann; Hermann Laferl; Michael Gschwantler; Franz Hac 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 182 KB

PHOENIX: A randomized controlled trial o

PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus

✍ Natalie Bzowej; David R. Nelson; Norah A. Terrault; Gregory T. Everson; Lichen L 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

The efficacy, tolerability, and safety of the prophylactic treatment of hepatitis C virus (HCV) after liver transplantation (LT) with peginterferon alfa-2a and ribavirin are not known. LT recipients with HCV were randomized to peginterferon alfa-2a/ribavirin treatment or observation 10 to 26 weeks p

The treatment of chronic hepatitis C wit

The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant

✍ Maria Rendina; Antonio Schena; Nicola Maurizio Castellaneta; Francesco Losito; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 135 KB